Division of Cardiac Surgery, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.
J Heart Lung Transplant. 2010 Dec;29(12):1380-7. doi: 10.1016/j.healun.2010.05.031. Epub 2010 Jul 14.
The ideal solution for recovery of donor lungs remains unknown. Low potassium dextran (LPD) solution is most common, but University of Wisconsin (UW) solution is also used. The United Network for Organ Sharing (UNOS) database allows assessment of preservation solutions in a large cohort of lung transplant (LTx) patients.
We retrospectively reviewed the UNOS data set for adult primary LTx patients (2005-2008) whose donor lungs were recovered with UW or LPD solution. Patients were stratified by UW vs LPD, and secondarily grouped by quartiles of the lung allocation score (LAS) to examine high-risk recipients. Kaplan-Meier (KM) short-term mortality (30 days, 90 days, 1 year) and rejection in the first year were examined for intervals with adequate follow-up. Cox proportional hazard regression using 11 variables examined all cause 1-year mortality.
Of 4,455 patients, 4,161 (93.4%) received LPD lungs and 294 (6.6%) received UW lungs, and 1,105 patients (24.8%) died during the study. There was no mortality difference based on flush solution with all patients examined together. However, patients in the upper 2 LAS quartiles (Q3: 37.8-45.4, Q4: > 45.4) receiving LPD lungs had greater 1-year survival of 81.5% vs 73.5% (p = 0.02). On multivariable analysis, flush with UW solution resulted in an increased risk of 1-year mortality (hazard ratio, 1.77. 95% confidence interval, 1.21-2.58; p = 0.003) vs LPD. Preservation solution did not affect rejection rates in the year after LTx. KM modeling demonstrated the effect of flush solution on survival (p = 0.02).
This study is the largest modern cohort to evaluate the effect of donor lung flush solutions on survival in adult LTx. UW solution increases the risk of 1-year mortality in high-risk LTx recipients.
目前,尚不清楚恢复供体肺的理想解决方案。低钾右旋糖酐(LPD)溶液最为常用,但也使用威斯康星大学(UW)溶液。器官共享联合网络(UNOS)数据库允许在大量肺移植(LTx)患者中评估保存液。
我们回顾性地审查了 UNOS 数据集,其中包括 2005 年至 2008 年接受 UW 或 LPD 溶液回收供体肺的成人原发性 LTx 患者。患者根据 UW 与 LPD 进行分层,其次根据肺分配评分(LAS)四分位数分为高风险受体亚组。对有足够随访时间的间隔进行 Kaplan-Meier(KM)短期死亡率(30 天、90 天、1 年)和第一年排斥反应的分析。使用 11 个变量的 Cox 比例风险回归分析了所有原因 1 年死亡率。
在 4455 例患者中,4161 例(93.4%)接受 LPD 肺,294 例(6.6%)接受 UW 肺,1105 例(24.8%)在研究期间死亡。在所有患者一起检查时,冲洗液对死亡率没有差异。但是,接受 LPD 肺的 LAS 前两个四分位数(Q3:37.8-45.4,Q4:> 45.4)的患者 1 年生存率更高,分别为 81.5%和 73.5%(p = 0.02)。多变量分析显示,与 LPD 相比,UW 溶液冲洗会增加 1 年死亡率的风险(危险比,1.77;95%置信区间,1.21-2.58;p = 0.003)。保存液不会影响 LTx 后一年的排斥反应率。KM 模型显示冲洗液对生存的影响(p = 0.02)。
本研究是评估成人 LTx 中供体肺冲洗液对生存率影响的最大现代队列研究。UW 溶液增加了高危 LTx 受者 1 年死亡率的风险。